Summary The influence of polymorphic variants of the human c-Ha-ras gene on predisposition to 
Mutation of cellular ras genes in the region of codons 12 or 61 has been shown to activate them, with respect to cellular transformation (Reddy et al., 1982; Yuasa et al., 1983) . However, mutationally activated ras genes appear to be present in only a minority of naturally occurring human tumours (Slamon et al., 1984; Fujita et al., 1984) . Goldfarb et al. (1982) showed that the human c-Ha-ras gene is located on a BamH 1 fragment of variable length. Capon et al. (1983) showed that the size difference between alleles mapped into a region of DNA consisting of tandem repeats of a 28 base pair (bp) consensus sequence, approximately one kilobase (kb) 3' of the polyadenylation signal of the gene (Figure 1 ). It seems likely that changes in the number of tandem repeat units are responsible for the RFLP's. Krontiris et al. (1985) characterised the c-Ha-ras RFLP frequency in groups of mixed cancer patients and unaffected individuals. They found that there were four common alleles of 6.9, 7.5, 8.0 and 8.3kb and occasional rare alleles that differed in length from the common alleles by up to 300 bp. The incidence of rare alleles was significantly higher in cancer patients than the normal population suggesting that these alleles predisposed to cancer.
In this study the c-Ha-ras polymorphism has been characterised in an unaffected population and the allele frequency compared to that in two groups of lung cancer patients. Kunkel et al. (1977) and from the solid tumour samples (25 of 66 non-SCCL cases) as described by Heighway and Hasleton (1986) .
(a) pT24-C3 carrying a 6.6kb BamHl fragment encoding the c-Ha-ras gene and region of tandem repeats (Reddy et al., 1982) .
(b) Human fl-globin gene fragment cloned on a 4.4kb Pstl fragment in pBR322 (Orkin et al., 1982) . (c) phTB3 encoding the human calcitonin gene (Allison et al., 1981) .
Southern analysis
Genomic DNA (10/pg) was digested with the stated restriction endonuclease and electrophoresed in a 0.8% agarose gel. The DNA was blotted onto nitrocellulose by the method of Southern (1975) . Plasmid DNA was nick translated using 32P to a specific activity of 2x 108 c.p.m. ,ug1 (Rigby et al., 1977) . Hybridisation, washing and autoradiography were carried out as described by Maniatis et al. (1982) . Fragment sizes were determined by comparison to a A phage DNA marker, digested with Hind III, 32P labelled and co-electrophoresed with the genomic samples. Statistical analysis Statistical analysis was carried out using Chi squared tests.
Results
To characterise the Ha-ras RFLP in the normal population the test DNA was digested with BamHl and probed in a series of Southern blots with nick translated pT24-C3. Four common alleles were identified corresponding to BamHl fragment sizes Figure 1. the fragment carrying the region of tandem repeats, with a variable molecular weight (fragment 2). This fragment was either 2.7, 3.2, 3.8 or 4.2kb in length corresponding to the four common alleles or had a value between 2.8 and 4.5kb for rare alleles. In 50 normal samples and 15 lung cancer patient samples the same allele pattern was identified in both BamHl and PvuII digests. As polymorphism was not observed at either recognition site future samples were screened with PvuII alone.
The allele frequencies observed in the unaffected control population and the two groups of lung cancer patients are shown in Table I . There was no significant difference in allele frequency between solid tumour and peripheral blood DNA samples in the cancer patients. The number of individuals carrying rare alleles in the unaffected population was 9/101 (9%) and in the cancer patients, SCCL 7/66 (10%), non-SCCL 8/66 (12%). There is therefore no significant difference between individuals in these groups and it appears that rare Ha-ras alleles do not pre-dispose individuals to lung cancer. The frequencies of the al, a2, a3 alleles are also not significantly different between the three groups. However, Table II shows that the a4 allele is present at a significantly higher level in the non-SCCL group when compared to the unaffected controls (P<0.05) and the SCCL group (P<0.004).
To ascertain if the higher level of the a4 allele in non-SCCL patients was a tumour specific change, matched tumour and peripheral blood or tumour and normal lung tissue samples were obtained from 15 patients. No allele pattern difference was observed between normal and tumour tissue suggesting that peripheral blood DNA reflected tumour allele phenotype and that the high level of the a4 allele was not due to a change in the repeat region length during tumour evolution. It therefore appears that the presence of the a4 allele predisposes an individual to SQCCL and ACL.
However, two of the tumour samples (SQCCL) with allele patterns of al, a4 (patient A) and a2, a4 (patient B) showed their non-a4 bands to be greatly reduced in hybridisation intensity (Figure 4) various allele patterns, two were found to have loss of material from the short arm of chromosome 11. (1985) reported that deletion of the region of tandem repeats from the cloned activated Ha-ras oncogene reduced efficiency of transformation after transfection. Deletion of this region was also found to reduce expression of the gene (Seeburg et al., 1984) . It is possible that variation in the size of the repeat region may alter expression or control of the Ha-ras gene which may in turn predispose certain cell types to malignancy.
An apparent loss of the non-a4 allele in tumour tissue from 2 out of 16 non-SCCL patients was observed. Fearon et al. (1985) showed loss of material from the short arm of chromosome 11 in five out of 12 transition cell carcinomas of the bladder and ureter, using the Ha-ras 
